Treatment of Sub-capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

Hip Fractures Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00663468
• Other study ID #: TLV-0021-08
• Status: Terminated
• Start date: April 2008
• Est. completion date: September 16, 2009

Study information

• Verified date: February 2020
• Source: Active Implants
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation.

1. determine changes in patient pain level

2. determine changes in patient functionality

3. determine changes in patient life quality

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 11
• Est. completion date: September 16, 2009
• Est. primary completion date: September 16, 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Female or male that is not younger than 60 years old.

• Patient suffers from hip fracture that will need hip arthroplasty.

• Patient that weight less than 150Kg

• Patient femur head diameter between 40mm - 50mm

• Mentally normal

• Patient that could walk before suffering from hip fracture

• Patient that willing to cooperate with the doctor

• Patient that signed on the acceptance form

Exclusion Criteria:

• Patient that does not willing to cooperate with the doctor

• Patient that is legally rejected

• Patient that suffer from cancer

• Patient that had passed amputation in is limbs

• Patient that is paralysis

• Patient that passed CVA or TIA

• Patient that still recovering from hard wounds or surgery

• Patient that suffer from infection in the hip joint

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fractures

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Active Implants